Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:brand
|
gptkbp:alternativeName |
gptkb:Dianabol
|
gptkbp:brand |
gptkb:methandrostenolone
|
gptkbp:class |
anabolic steroid
|
gptkbp:compatibleWith |
gptkb:FDA
|
gptkbp:controlledSubstanceSchedule |
gptkb:Canada
gptkb:United_Kingdom gptkb:United_States |
gptkbp:developedBy |
1950s
|
https://www.w3.org/2000/01/rdf-schema#label |
Anabol
|
gptkbp:marketedIn |
various countries
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
water retention
acne liver toxicity gynecomastia |
gptkbp:usedBy |
bodybuilders
|
gptkbp:usedFor |
muscle growth
|
gptkbp:bfsParent |
gptkb:methandrostenolone
|
gptkbp:bfsLayer |
8
|